ARELIVON Trademark

Trademark Overview

On Friday, May 4, 2007, a trademark application was filed for ARELIVON with the United States Patent and Trademark Office. The USPTO has given the ARELIVON trademark a serial number of 77172781. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 14, 2011. This trademark is owned by Glaxo Group Limited. The ARELIVON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines
arelivon

General Information

Serial Number77172781
Word MarkARELIVON
Filing DateFriday, May 4, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 14, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 23, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 8, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, February 14, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 14, 2011ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 10, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 9, 2010EXTENSION 5 GRANTED
Tuesday, July 6, 2010EXTENSION 5 FILED
Tuesday, July 6, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 4, 2010EXTENSION 4 GRANTED
Friday, December 11, 2009EXTENSION 4 FILED
Friday, December 11, 2009TEAS EXTENSION RECEIVED
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 19, 2009EXTENSION 3 GRANTED
Tuesday, June 16, 2009EXTENSION 3 FILED
Tuesday, June 16, 2009TEAS EXTENSION RECEIVED
Monday, January 12, 2009EXTENSION 2 GRANTED
Monday, December 15, 2008EXTENSION 2 FILED
Monday, January 12, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 15, 2008TEAS EXTENSION RECEIVED
Friday, July 25, 2008EXTENSION 1 GRANTED
Tuesday, July 15, 2008EXTENSION 1 FILED
Friday, July 25, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 15, 2008TEAS EXTENSION RECEIVED
Tuesday, January 15, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 23, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 3, 2007NOTICE OF PUBLICATION
Tuesday, September 18, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 6, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 27, 2007EXAMINER'S AMENDMENT ENTERED
Monday, August 27, 2007ASSIGNED TO LIE
Monday, August 27, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 27, 2007EXAMINERS AMENDMENT E-MAILED
Monday, August 27, 2007EXAMINERS AMENDMENT -WRITTEN
Friday, August 17, 2007ASSIGNED TO EXAMINER
Tuesday, May 8, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

arelivon treatment disorders diseases respiratory neurological gastrointestinal dysfunction ophthalmological hepatological hormonal